ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.640
+0.050 (3.14%)
At close: Apr 28, 2026, 4:00 PM EDT
1.670
+0.030 (1.83%)
After-hours: Apr 28, 2026, 4:33 PM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $220.68 million as of April 28, 2026. Its market cap has increased by 761.20% in one year.
Market Cap
220.68M
Enterprise Value
182.58M
1-Year Change
761.20%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $220.68M, a decrease of -79.11%. That is a compound annual growth rate of -23.73%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 235.81M |
| Nuvectis Pharma | 235.78M |
| Milestone Pharmaceuticals | 231.81M |
| Camp4 Therapeutics | 230.52M |
| Polaryx Therapeutics | 229.61M |
| Keros Therapeutics | 226.95M |
| Voyager Therapeutics | 225.88M |
| Heron Therapeutics | 224.48M |